1,083
Views
27
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Blood vessels as targets in tumor therapy

Pages 178-186 | Received 15 Oct 2011, Accepted 16 Jan 2012, Published online: 21 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lena Claesson-Welsh. (2020) Oxygen sensing; a stunningly elegant molecular machinery highjacked in cancer. Upsala Journal of Medical Sciences 125:3, pages 205-210.
Read now
Rasoul Baharlou, Nader Tajik, Mahdi Behdani, Mohammad Ali Shokrgozar, Vajiheh Tavana, Fatemeh Kazemi-Lomedasht, Fatemeh Faraji & Mahdi Habibi-Anbouhi. (2018) An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization. Immunopharmacology and Immunotoxicology 40:5, pages 368-374.
Read now

Articles from other publishers (25)

Bin Yu, Hong-Dan Zhu, Xiao-Liang Shi, Pan-Pan Chen, Xiang-Mei Sun, Gui-Yu Xia, Min Fang, Yong-Xing Zhong, Xiao-Li Tang, Tao Zhang & Hai-Tao Pan. (2021) iTRAQ-based quantitative proteomic analysis of thoracic aortas from adult rats born to preeclamptic dams. Clinical Proteomics 18:1.
Crossref
Martin Metzenmacher, Filippo Rizzo, Kato Kambartel, Jens Panse, Diana Schaufler, Matthias Scheffler, Ivo Azeh, Mathias Hoiczyk, Amin T Turki, Judith Atz, Hannes Buchner, Christopher Hoffmann & Daniel C Christoph. (2021) Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma. Future Oncology 17:30, pages 3965-3976.
Crossref
Weimin Yang, Shuangfeng Chen, Houfack Mickael, Liangheng Xu, Yueping Xia, Chao Cong, Yike Zhang, Zhongyao Qian, Tengyuan Li, Daqiao Wei, Wenhai Yu & Fen Huang. (2021) Uterine Injury Caused by Genotype 4 Hepatitis E Virus Infection Based on a BALB/c Mice Model. Viruses 13:10, pages 1950.
Crossref
Leif Jansson & Per‐Ola Carlsson. 2011. Comprehensive Physiology. Comprehensive Physiology 799 837 .
Yanling Xu, Zhenzhong Su, Junyao Li, Qi Wang, Guangping Meng, Yu Zhang, Wen Yang, Jie Zhang & Peng Gao. (2018) Role of RNA‑binding protein 5 in the diagnosis and chemotherapeutic response of lung cancer (Review). Oncology Letters.
Crossref
Rasoul Baharlou, Nader Tajik, Mahdi Habibi-Anbouhi, Mohammad Ali Shokrgozar, Amir-Hassan Zarnani, Fatemeh Shahhosseini & Mahdi Behdani. (2018) Generation and characterization of an anti-delta like ligand-4 Nanobody to induce non-productive angiogenesis. Analytical Biochemistry 544, pages 34-41.
Crossref
Afsane Bahrami, Seyed Mahdi Hassanian, Majid Khazaei, Malihe Hasanzadeh, Soodabeh Shahidsales, Mina Maftouh, Gordon A. Ferns & Amir Avan. (2017) The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress. Journal of Cellular Biochemistry 119:1, pages 111-122.
Crossref
Robert RoskoskiJr.Jr.. (2017) Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas. Pharmacological Research 120, pages 116-132.
Crossref
E. Bronte, A. Galvano, G. Novo & A. Russo. 2017. Cardio-Oncology. Cardio-Oncology 69 89 .
Kellsye L. Fabian & Walter J. Storkus. 2017. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy 191 211 .
G.-G. Li, Z.-Z. Guo, X.-F. Ma, N. Cao, S.-N. Geng, Y.-Q. Zheng, M.-J. Meng, H.-H. Lin, G. Han & G.-J. Du. (2016) The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis. Developmental & Comparative Immunology 59, pages 89-98.
Crossref
Kellsye L. Fabian & Walter J. Storkus. 2016. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy 51 76 .
A. P. Trashkov, N. A. Verlov, N. V. Tsygan, M. R. Artemenko, V. A. Pechatnikova, A. G. Vasiliev, R. V. Korablev & T. A. Verlova. (2015) Neoangiogenesis control in oncology: mechanisms and prospects of practical application. Regional blood circulation and microcirculation 14:4, pages 11-17.
Crossref
François Planeix, Mohammad-Ahsan Siraj, François-Clément Bidard, Blaise Robin, Christophe Pichon, Xavier Sastre-Garau, Martine Antoine & Nicolae Ghinea. (2015) Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Tomohiro Shinya, Tsubasa Yokota, Shiori Nakayama, Sayuri Oki, Junpei Mutoh, Satoru Takahashi & Keizo Sato. (2015) Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice. Journal of Pharmacology and Experimental Therapeutics 354:3, pages 269-278.
Crossref
Ingunn M. Stefansson, Maria Raeder, Elisabeth Wik, Monica Mannelqvist, Kanthida Kusonmano, Gøril Knutsvik, Ingfrid Haldorsen, Jone Trovik, Anne M. Øyan, Karl-H. Kalland, Anne Cathrine Staff, Helga B. Salvesen & Lars A. Akslen. (2015) Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. Oncotarget 6:12, pages 10634-10645.
Crossref
Shuji Kitahara, Yasuhiro Suzuki, Masae Morishima, Asuka Yoshii, Sachiko Kikuta, Kazuhiko Shimizu, Shunichi Morikawa, Yasufumi Sato & Taichi Ezaki. (2014) Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. Molecular Cancer 13:1.
Crossref
Jia Wang, Ling Dong, Lixia Xu, Eagle S.H. Chu, Yangchao Chen, Jiayun Shen, Xiaoxing Li, Chi Chun Wong, Joseph J.Y. Sung & Jun Yu. (2014) B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Cancer Letters 355:2, pages 192-200.
Crossref
Mathumai Kanapathipillai, Amy Brock & Donald E. Ingber. (2014) Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Advanced Drug Delivery Reviews 79-80, pages 107-118.
Crossref
Kenkichi Sugimoto, Suzuka Yoshida, Yuka Mashio, Naoka Toyota, Yanjiang Xing, Henan Xu, Yuki Fujita, Zhijun Huang, Maki Touma & Qiong Wu. (2014) Role of FGF10 on tumorigenesis by MS-K. Genes to Cells 19:2, pages 112-125.
Crossref
Kenji Kadomatsu, Péter Bencsik, Anikó Görbe, Csaba Csonka, Kazuma Sakamoto, Satoshi Kishida & Péter Ferdinandy. (2014) Therapeutic potential of midkine in cardiovascular disease. British Journal of Pharmacology 171:4, pages 936-944.
Crossref
U. Lindahl & L. Kjellén. (2013) Pathophysiology of heparan sulphate: many diseases, few drugs. Journal of Internal Medicine 273:6, pages 555-571.
Crossref
DAVID FEDER, FABIO F. PERRAZO, EDIMAR C. PEREIRA, SILVANA FORSAIT, CECILIA K.R. FEDER, PAULO E.B. JUNQUEIRA, VIRGINIA B.C. JUNQUEIRA, LIGIA A. AZZALIS & FERNANDO L.A. FONSECA. (2013) Standardization of a method to study angiogenesis in a mouse model. Anais da Academia Brasileira de Ciências 85:4, pages 1483-1487.
Crossref
Melanie Hein & Shannon Graver. (2013) Tumor cell response to bevacizumab single agent therapy in vitro. Cancer Cell International 13:1, pages 94.
Crossref
Shur-Jen Wang, Stanley J. F. Laulederkind, G. T. Hayman, Jennifer R. Smith, Victoria Petri, Timothy F. Lowry, Rajni Nigam, Melinda R. Dwinell, Elizabeth A. Worthey, Diane H. Munzenmaier, Mary Shimoyama & Howard J. Jacob. (2013) Analysis of disease-associated objects at the Rat Genome Database. Database 2013.
Crossref